United Therapeutics (UTHR) - 12 Year Stock Split History

Historical stock splits for United Therapeutics since 2006. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $1.725B
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.578B 11.25
Zoetis (ZTS) United States $41.332B 32.60
Grifols (GRFS) Spain $14.271B 18.50
Jazz Pharmaceuticals (JAZZ) Ireland $10.677B 17.96
Neurocrine Biosciences (NBIX) United States $9.332B 0.00
Nektar Therapeutics (NKTR) United States $8.412B 0.00
Sage Therapeutics (SAGE) United States $7.844B 0.00
Catalent (CTLT) United States $5.780B 26.92
Ionis Pharmaceuticals (IONS) United States $5.754B 0.00
FibroGen (FGEN) United States $5.379B 0.00
Loxo Oncology (LOXO) United States $5.329B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.485B 18.38
Madrigal Pharmaceuticals (MDGL) United States $4.114B 0.00
Ironwood Pharmaceuticals (IRWD) United States $3.048B 0.00
Aerie Pharmaceuticals (AERI) United States $2.919B 0.00
Heron Therapeutics (HRTX) United States $2.806B 0.00
USANA Health Sciences (USNA) United States $2.691B 25.88
Portola Pharmaceuticals (PTLA) United States $2.628B 0.00
Endo (ENDP) Ireland $2.511B 3.42
Spectrum Pharmaceuticals (SPPI) United States $2.473B 0.00
Enanta Pharmaceuticals (ENTA) United States $2.372B 43.82
Xencor (XNCR) United States $2.354B 0.00
TESARO (TSRO) United States $2.206B 0.00
Zogenix (ZGNX) United States $2.076B 0.00
PTC Therapeutics (PTCT) United States $1.698B 0.00
Corcept Therapeutics (CORT) United States $1.523B 25.42
Pacira Pharmaceuticals (PCRX) United States $1.507B 0.00
TherapeuticsMD (TXMD) United States $1.453B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.442B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.428B 0.00
Impax Laboratories (AMRX) United States $1.366B 29.35
ImmunoGen (IMGN) United States $1.326B 0.00
Radius Health (RDUS) United States $1.294B 0.00
Tricida (TCDA) United States $1.201B 0.00
Endocyte (ECYT) United States $1.188B 0.00
Esperion Therapeutics (ESPR) United States $1.155B 0.00
Flexion Therapeutics (FLXN) United States $1.024B 0.00
OptiNose (OPTN) United States $1.005B 0.00
Karyopharm Therapeutics (KPTI) United States $0.957B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.812B 0.00
GlycoMimetics (GLYC) United States $0.700B 0.00
Dova Pharmaceuticals (DOVA) United States $0.687B 0.00
Collegium Pharmaceutical (COLL) United States $0.662B 0.00
Translate Bio (TBIO) United States $0.657B 0.00
Aclaris Therapeutics (ACRS) United States $0.631B 0.00
Odonate Therapeutics (ODT) United States $0.624B 0.00
CASI Pharmaceuticals (CASI) United States $0.613B 0.00
ChemoCentryx (CCXI) United States $0.605B 42.41
BioCryst Pharmaceuticals (BCRX) United States $0.599B 0.00
Akebia Therapeutics (AKBA) United States $0.598B 0.00
Siga Technologies (SIGA) United States $0.572B 0.00
Depomed (DEPO) United States $0.520B 0.00
ArQule (ARQL) United States $0.498B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.487B 0.00
Lannett Co Inc (LCI) United States $0.487B 4.48
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.483B 0.00
Forty Seven (FTSV) United States $0.471B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.466B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.460B 0.00
ElectroCore (ECOR) United States $0.450B 0.00
Majesco Entertainment (COOL) United States $0.436B 0.00
Dermira (DERM) United States $0.421B 0.00
Mast Therapeutics (SVRA) United States $0.391B 0.00
Concert Pharmaceuticals (CNCE) United States $0.389B 0.00
Xeris Pharmaceuticals (XERS) United States $0.377B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.338B 26.37
Achaogen (AKAO) United States $0.332B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.327B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.325B 0.00
Minerva Neurosciences (NERV) United States $0.318B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.316B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.311B 0.00
Neon Therapeutics (NTGN) United States $0.310B 0.00
Tyme Technologies (TYME) United States $0.302B 0.00
Zafgen (ZFGN) United States $0.301B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.255B 0.00
Jounce Therapeutics (JNCE) United States $0.253B 0.00
DURECT (DRRX) United States $0.244B 0.00
Ocular Therapeutix (OCUL) United States $0.240B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.239B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.231B 0.00
ProNAi Therapeutics (SRRA) Canada $0.224B 0.00
Redhill Biopharma (RDHL) Israel $0.220B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.219B 0.00
Galectin Therapeutics (GALT) United States $0.219B 0.00
Immune Design (IMDZ) United States $0.214B 0.00
Aratana Therapeutics (PETX) United States $0.212B 0.00
Ardelyx (ARDX) United States $0.209B 0.00
IMV INC (IMV) Canada $0.207B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.207B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.204B 0.00
Melinta Therapeutics (MLNT) United States $0.190B 0.00
ContraFect (CFRX) United States $0.180B 0.00
Neos Therapeutics (NEOS) United States $0.177B 0.00
Nature's Sunshine Products (NATR) United States $0.173B 0.00
MediWound (MDWD) Israel $0.170B 0.00
Adherex Technologies (FENC) United States $0.170B 0.00
Calithera Biosciences (CALA) United States $0.167B 0.00
Aldeyra Therapeutics (ALDX) United States $0.162B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.159B 0.00
Opexa Therapeutics (ACER) United States $0.153B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.151B 0.00
MEI Pharma (MEIP) United States $0.151B 0.00
Cardiome Pharma (CORV) Canada $0.141B 0.00
Molecular Templates (MTEM) United States $0.136B 0.00
CTI BioPharma (CTIC) United States $0.132B 0.00
Forward Pharma (FWP) Denmark $0.129B 0.00
Juniper Pharmaceuticals (JNP) United States $0.127B 190.83
Adamis Pharmaceuticals (ADMP) United States $0.122B 0.00
SteadyMed (STDY) Israel $0.120B 0.00
Recro Pharma (REPH) United States $0.117B 0.00
Iterum Therapeutics (ITRM) Ireland $0.117B 0.00
Otonomy (OTIC) United States $0.113B 0.00
Nivalis Therapeutics (ALPN) United States $0.113B 0.00
Rafael Holdings (RFL) United States $0.113B 0.00
Infinity Pharmaceuticals (INFI) United States $0.111B 0.00
Affimed (AFMD) Germany $0.111B 0.00
Champions Oncology (CSBR) United States $0.098B 0.00
BioLineRx (BLRX) Israel $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 0.00
KalVista Pharmaceuticals (KALV) United States $0.092B 0.00
SCYNEXIS (SCYX) United States $0.087B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.084B 0.00
Trillium Therapeutics (TRIL) Canada $0.077B 0.00
Novan (NOVN) United States $0.077B 0.00
Natural Alternatives (NAII) United States $0.077B 9.85
KemPharm (KMPH) United States $0.070B 0.00
Genocea Biosciences (GNCA) United States $0.068B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.066B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.061B 0.00
Mannatechorporated (MTEX) United States $0.055B 13.37
Capnia (SLNO) United States $0.054B 0.00
Heat Biologics (HTBX) United States $0.048B 0.00
Avenue Therapeutics (ATXI) United States $0.044B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.040B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.038B 34.67
Onconova Therapeutics (ONTX) United States $0.037B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.035B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.035B 0.00
Xenetic Biosciences (XBIO) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.90
Dipexium Pharmaceuticals (PLXP) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Biomerica (BMRA) United States $0.034B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.031B 0.00
IsoRay (ISR) United States $0.031B 0.00
Regulus Therapeutics (RGLS) United States $0.030B 0.00
Lipocine (LPCN) United States $0.029B 0.00
Shineco (TYHT) China $0.029B 2.49
NanoViricides (NNVC) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.025B 0.00
Cyanotech (CYAN) United States $0.023B 21.67
Aradigm (ARDM) United States $0.022B 0.00
Aviragen Therapeutics (VXRT) United States $0.022B 0.00
ESSA Pharma (EPIX) Canada $0.021B 0.00
Midatech Pharma (MTP) United Kingdom $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.021B 0.00
Egalet (EGLT) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Intellipharmaceutics (IPCI) Canada $0.017B 0.00
Aralez Pharmaceuticals (ARLZ) Canada $0.017B 0.00
Pain Therapeutics (PTIE) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
Skyline Medical (AIPT) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
India Globalization Capital (IGC) United States $0.014B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.010B 0.00
PharmAthene (ALT) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
RXi Pharmaceuticals (RXII) United States $0.008B 0.00
Biostar Pharmaceuticals (BSPM) China $0.006B 3.17
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00